iShares Biotechnology ETF surges 26% over three months to September 4
AI Summary- iShares Biotechnology ETF gained 26% over three months ending September 4, 2026.
- IBB outperformed the S&P 500's 4% gain by 22 percentage points.
- Large pharmaceutical companies acquired mid- and small-cap biotech firms to offset rev...